Synthesis and in vitro evaluation of antibacterial and antibiofilm activities of novel triphenylphosphonium‐functionalized substituted pyrimidines

Liubov V. Muzychka,Nataliia I. Humeniuk,Iryna O. Boiko,Nina O. Vrynchanu,Oleg B. Smolii
DOI: https://doi.org/10.1111/cbdd.14483
2024-02-16
Chemical Biology & Drug Design
Abstract:In this study, triphenylphosphonium‐containing substituted pyrimidines were synthesized and evaluated for their antibacterial and antibiofilm activities against S. aureus 222, E. coli 311, and P. aeruginosa 449. Compounds 2a and 11 showed a significant reduction in biofilm formation of S. aureus 222 and E. coli 311 by 76.5%–99.1%. The increase in the prevalence of antibiotic‐resistant pathogens leads to a decrease in the number of antimicrobial agents for the treatment of infections and prompts researchers to search for new effective antimicrobial drugs. This study reports the synthesis of novel triphenylphosphonium‐functionalized substituted pyrimidines and in vitro evaluation of their antibacterial and antibiofilm activity. Most of the synthesized derivatives showed high antibacterial activity (MIC = 0.39–1.56 μg/mL) against the methicillin‐resistant strain of S. aureus 222. Compounds 2a and 11 exhibited a high level of antibiofilm activity against S. aureus 222 and E. coli 311. The triphenylphosphonium‐containing pyrimidines 11 and 2a reduced S. aureus 222 biofilm formation by 99.1% and 95.8%, respectively. In addition, compound 2a was the most active against E. coli 311 biofilm formation (the biomass decreased by 98.4%).
biochemistry & molecular biology,chemistry, medicinal
What problem does this paper attempt to address?